CSP Inc. Announces Filing Extension for Form 10-Q
May 15, 2017 13:03 pm UTC| Business
LOWELL, Mass., May 15, 2017 -- CSP Inc.(NASDAQ:CSPI) today announced that the Company will file a Form 12b-25 notification of late filing with theSecurities and Exchange Commissionto receive a five day extension to file...
Newtek Small Business Finance, LLC Increases Capital One Revolving Credit Facility to $100.0 Million
May 15, 2017 13:03 pm UTC| Business
LAKE SUCCESS, N.Y., May 15, 2017 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (Nasdaq:NEWT), an internally managed business development company ("BDC"), today announced that Newtek Small Business...
Newtek Small Business Finance, LLC Increases Capital One Revolving Credit Facility to $100.0 Million
May 15, 2017 13:03 pm UTC| Business
LAKE SUCCESS, N.Y., May 15, 2017 -- Newtek Business Services Corp. (“Newtek” or the “Company”), (Nasdaq:NEWT), an internally managed business development company ("BDC"), today announced that Newtek Small Business...
New Jersey Mining Company Provides First Quarter Update on Operations and Corporate Activities
May 15, 2017 13:03 pm UTC| Business
COEUR DALENE, Idaho, May 15, 2017 -- New Jersey Mining Company (OTCQB:NJMC) (“NJMC” or the “Company”) today provided its First Quarter update on operations at its Golden Chest Mine and corporate activities. ...
New Jersey Mining Company Provides First Quarter Update on Operations and Corporate Activities
May 15, 2017 13:03 pm UTC| Business
COEUR DALENE, Idaho, May 15, 2017 -- New Jersey Mining Company (OTCQB:NJMC) (“NJMC” or the “Company”) today provided its First Quarter update on operations at its Golden Chest Mine and corporate activities. ...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...
AXIM Biotech Clinical Study to Develop Bioequivalent Product to Marinol Listed on Clinicaltrials.gov
May 15, 2017 13:03 pm UTC| Business
NEW YORK, May 15, 2017 -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that information on the company’s Bioavailability Study on...